These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Scopolamine bioavailability in combined oral and transdermal delivery. Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371 [TBL] [Abstract][Full Text] [Related]
47. Controlled topical delivery of drugs for systemic action. Shaw JE; Chandrasekaran SK Drug Metab Rev; 1978; 8(2):223-33. PubMed ID: 363384 [No Abstract] [Full Text] [Related]
48. Theory of antimotion sickness drug mechanisms. Wood CD; Graybiel A Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925 [No Abstract] [Full Text] [Related]
49. alpha-Fluoromethylhistidine but not diphenhydramine prevents motion-induced emesis in the cat. Lucot JB; Takeda N Am J Otolaryngol; 1992; 13(3):176-80. PubMed ID: 1626619 [TBL] [Abstract][Full Text] [Related]
50. Side effects of transdermal scopolamine. Wilkinson JA J Emerg Med; 1987; 5(5):389-92. PubMed ID: 3668203 [TBL] [Abstract][Full Text] [Related]
51. [Prevention of kinetosis in children. Transdermal therapy with scopolamine]. Müller M; Besch W; Steilner D Fortschr Med; 1987 Feb; 105(4):82, 86-7. PubMed ID: 3557264 [No Abstract] [Full Text] [Related]
52. Neural mechanisms of motion sickness. Takeda N; Morita M; Horii A; Nishiike S; Kitahara T; Uno A J Med Invest; 2001 Feb; 48(1-2):44-59. PubMed ID: 11286016 [TBL] [Abstract][Full Text] [Related]
53. Effects of drug countermeasures for space motion sickness on working memory in humans. Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046 [TBL] [Abstract][Full Text] [Related]
54. What you thought you knew about motion sickness isn't necessarily so. Cowings PS; Malmstrom FV Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877 [TBL] [Abstract][Full Text] [Related]
55. Air-sickness in preventible: why not prevent it? LANE JC Med J Aust; 1954 Mar; 41(1 13):465-7. PubMed ID: 13164635 [No Abstract] [Full Text] [Related]
56. [Prophylactic and sensitizing effects of biologically active substances in animal modeling of vestibular disorders]. Shashkov VS; Drozd IuV; Puko VM Kosm Biol Aviakosm Med; 1991; 25(5):61-3. PubMed ID: 8577151 [No Abstract] [Full Text] [Related]
58. [Study of the efficacy and side effects of various antinaupathic drugs]. Galban P; Gouars M; Guillermin M Rev Corps Sante Armees Terre Mer Air; 1972 Oct; 13(5):497-509. PubMed ID: 4264457 [No Abstract] [Full Text] [Related]
59. A novel animal model for motion sickness and its first application in rodents. Yu XH; Cai GJ; Liu AJ; Chu ZX; Su DF Physiol Behav; 2007 Nov; 92(4):702-7. PubMed ID: 17612582 [TBL] [Abstract][Full Text] [Related]